The safety evidence from TRAVERSE refers to men with confirmed low testosterone levels — below 300 nanograms per decilitre of ...
Experts think certain non-routine tests are worth asking your doctor about, since the results could point to health-saving ...
Patients with mild autonomous cortisol secretion show bone microstructural deterioration despite normal areal BMD on routine DXA scans.
GLP-1S HAVE BEEN called “wonder drugs” for how they have revolutionized weight loss, and they’re being explored for their ...
The Atellica TSTII Testosterone assay is the only immunoassay with CDC HoST-TT Certification; Certification reaffirms assay res ...
Phase 3 trial data show a synthetic semaglutide injection provides glycemic control comparable to Ozempic in patients with type 2 diabetes.
“Correctly identifying low blood sugar in patients without diabetes is a key step before seeking a cause for hypoglycemia,” ...
Total Revenue -- $164.9 million, up from $157.2 million the previous year; reflects increasing prescriptions and patient volume. Prescription Trends -- Record levels of new prescriptions, new patient ...
After years of worsening pain, irregular periods and soaring hormone levels, doctors discovered it wasn't her reproductive ...
Hypercortisolism is at least as common as hyperaldosteronism, and some people with resistant hypertension have both.
David Toro-Tobon and colleagues argue that “clinician in the loop” is shifting responsibility for AI safety from developers ...
Doctors warn that “Low T” is being expanded beyond clinical limits, driven by clinics, influencers, and modern masculinity ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results